2-(4-phenyl-1-piperidinyl)cyclohexanol,
2-(4-phenylpiperidino)cyclohexanol,
AH 5183,
AH-5183,
methylvesamicol,
vesamicol,
vesamicol hydrochloride,
vesamicol hydrochloride, (+,-)-,
vesamicol, (+,-)-,
VESAMICOL HYDROCHLORIDE,
120447-62-3,
AH 5183 hydrochloride,
AH-5183 hydrochloride,
2-(4-Phenylpiperidino)cyclohexanol hydrochloride,
Cyclohexanol, 2-(4-phenylpiperidino)-, hydrochloride,
(+/-)-Vesamicol HCl (AH-5183),
AH-5183,
23965-53-9,
V-100,
SR-01000075352,
(+/-)-VESAMICOL,
AC1L4SHB,
(+/-)-Vesamicol HCl,
D-(+)-VESAMICOL,
( inverted exclamation markA)-2-(4-phenylpiperidino)cyclohexanol hydrochloride,
(y)-Vesamicol hydrochloride,
AC1Q3F8M,
(?)-Vesamicol hydrochloride,
L(-)-vesamicol hydrochloride,
SPECTRUM2300309,
CHEMBL1256846,
CTK8F1086,
HMS1570H22,
HMS1922L20,
Pharmakon1600-02300309,
Tox21_501228,
MFCD00055231,
NSC759580,
CCG-222532,
LP01228,
NSC-759580,
(+/-)-Vesamicol.HCl (AH-5183),
NCGC00094470-01,
NCGC00094470-02,
NCGC00094470-03,
NCGC00094470-04,
NCGC00261913-01,
LS-57227,
RT-016206,
(+/-)-2-(4-Phenylpiperidino) cyclohexanol,
EU-0101228,
(+/-)-Vesamicol hydrochloride, >98%, solid,
( inverted question mark)-Vesamicol hydrochloride,
J-004345,
SR-01000075352-1,
AH-5183((+/-)-2-(4-Phenylpiperidino) cyclohexanol,
( inverted exclamation markA)-Vesamicol HCl (AH-5183),
(+/-)-2-(4-Phenylpiperidino)cyclohexanol hydrochloride,
2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol hydrochloride,
(+/-)-Vesamicol hydrochloride,
C17H25NO.HCl,
( )-Vesamicol hydrochloride,
C17-H25-N-O.Cl-H,
KST-1A3392,
AR-1A0220,
CID212231,
112709-60-1,
27619-88-1,